Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

Update Il y a 4 ans
Reference: NCT00674362

Woman and Man

Extract

To assess the clinical efficacy and safety of certolizumab pegol as add-on therapy with stable-dose disease-modifying antirheumatic drugs (DMARDs) for achieving clinical remission in patients with moderate to low disease activity rheumatoid arthritis


Inclusion criteria

  • Rheumatoid Arthritis


Links